Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurovascular and Immuno-Imaging Symposium
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
8th Annual Symposium on Glial-Neuronal Interactions
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
CinnoVex home page
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
ForuMS: A Virtual Journal Club for MS Clinicians

Pages